St. Jude Medical also announced FDA approval of additional quadripolar pacing Quartet LV leads, which can be used with MultiPoint Pacing technology, as well as the programmer-based Auto VectSelect Quartet™ Test. The two new leads are designed based on the company’s first-to-market, clinically proven Quadripolar LV lead technology and include additional electrode spacing options on two new S-curve shaped lead designs. The expanded family of Quartet LV leads offers more options to effectively meet the needs of patients with larger as well as smaller cardiac anatomies. Physicians can quickly customize therapy using the new automated Auto VectSelect Quartet Test, which is designed to offer comprehensive testing results so appropriate therapy options can be easily and efficiently programmed for each patient in a streamlined workflow.

“Continuing our quadripolar leadership, MultiPoint Pacing represents our commitment to invest and innovate in state of the art heart failure treatment options,” said Philip Ebeling, vice president and chief technology officer for St. Jude Medical. “These additions to our comprehensive CRT portfolio are examples of St. Jude Medical’s focus on providing physicians with technologies that result in effective patient outcomes and transform the treatment of some of the world’s most expensive epidemic diseases.”


St. Jude Medical developed and launched the industry’s first quadripolar pacing system in the U.S. in 2011 featuring four pacing electrodes, offering physicians the ability to effectively and efficiently manage the ever-changing needs of patients with heart failure. The Quartet LV lead design allows the physician to implant the lead in the most stable position without making trade-offs in electrical performance; this also has been demonstrated to reduce the likelihood of costly and invasive lead revision through a second intervention procedure. MultiPoint Pacing technology shifts the treatment options from a single point of pacing to multiple quadripolar pacing offerings that provide physicians more advanced options to optimize CRT performance.

About St. Jude Medical’s Heart Failure Business

St. Jude Medical is pioneering heart failure disease management with innovative solutions like the CardioMEMS™ HF System, ground-breaking quadripolar technology, our first-to-market MultiPoint™ Pacing technology and, in select European markets, the HeartMate 3™ left ventricular assist system. St. Jude Medical collaborates with heart failure specialists, clinicians and advocacy partners to provide innovative, cost-effective solutions that help reduce hospitalizations and improve patient quality of life for heart failure patients around the world.

More HCB News